CNBX PHARMACEUTICALS INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
CNBX PHARMACEUTICALS INC. (CNBX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $0 for the 6-month period ending 2026-02-28, per its 10-Q filed 2026-04-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-04-14
- CNBX PHARMACEUTICALS INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $0.00.
- CNBX PHARMACEUTICALS INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$4.85K.
- CNBX PHARMACEUTICALS INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was $0.00.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|
| 2026-02-28 | $0.00 10-Q · filed 2026-04-14 | ||
| 2025-02-28 | $0.00 10-Q · filed 2026-04-14 | ||
| 2024-05-31 | $0.00 10-Q · filed 2024-07-15 | ||
| 2024-02-29 | $59.89K 10-Q · filed 2025-04-14 | ||
| 2023-08-31 | $0.00 10-K · filed 2023-11-30 | ||
| 2023-05-31 | $0.00 10-Q · filed 2024-07-15 | ||
| 2023-02-28 | $0.00 10-Q · filed 2024-04-16 | ||
| 2022-08-31 | -$4.85K 10-K · filed 2023-11-30 | ||
| 2022-05-31 | $0.00 10-Q · filed 2023-07-14 | ||
| 2021-08-31 | $0.00 10-K · filed 2022-11-30 | ||
| 2021-05-31 | $0.00 10-Q · filed 2022-07-14 |